Formex, LLC ("Formex"), a leader in pharmaceutical development and manufacturing, announced that Mr. Steve Massah has joined Formex as President & CEO effective March 17th 2014.
Formex's Mission-
To provide our clients with superior services by developing innovations and solutions that address the needs of each client's API.
Formex provides innovative solutions to our client's drug development challenges that span formulation development through clinical and commercial cGMP manufacturing.
»Read More about our Mission Statement
Formex is a leading specialty contract pharmaceutical development and manufacturing organization focusing on oral and topical dosage forms.
Formex has built a reputation for delivering novel and innovative solutions to challenging problems in pharmaceutical product development, manufacturing, and analytical services. The company provides contract services for clients that vary from small virtual companies with no R&D or manufacturing facilities to the largest pharmaceutical organizations.
Formex specializes in bioavailability enhancement and controlled release technologies, such as hot melt extrusion, spray-drying, fluid bed processing, and liquid/semi-solid filled hard capsules. Our extensive bioavailability enhancement technologies combined with our drug delivery expertise enables us to overcome many of the most difficult solubility challenges.
From solid dispersions to controlled release, Formex creates customized solutions to meet each molecule’s specific needs that help our clients reach their development targets, reduce development costs and accelerate time-to-market.
Products are made under Formex Quality Assurance supervision utilizing the highest quality standards in accordance with FDA and other regulations.
We take pride in providing exceptional service by listening and responding to the individual needs of each client.